ACUTE AND SUBCHRONIC TOXICITY OF THYMOQUINONE IN MICE

Citation
Oa. Badary et al., ACUTE AND SUBCHRONIC TOXICITY OF THYMOQUINONE IN MICE, Drug development research, 44(2-3), 1998, pp. 56-61
Citations number
31
Categorie Soggetti
Chemistry Medicinal","Pharmacology & Pharmacy
Journal title
ISSN journal
02724391
Volume
44
Issue
2-3
Year of publication
1998
Pages
56 - 61
Database
ISI
SICI code
0272-4391(1998)44:2-3<56:AASTOT>2.0.ZU;2-J
Abstract
The effects of acute and subchronic administration of thymoquinone (TQ ), the main constituent of the volatile oil of the black seeds Nigella sativa, with significant cytoprotective properties, were studied in m ale Swiss albino mice. After acute oral administration, the LD50 value (95% CL) was 2.4 g/kg (1.52-3.77). Signs of toxicity at high doses we re hypoactivity and difficulty in respiration. Twenty-four hours after TQ (2 and 3 g/kg) administration, a significant reduction in tissue ( liver, kidneys, and heart) reduced glutathione (GSH) content was obser ved. Plasma urea and creatinine concentrations and the enzyme activiti es of alanine amino transferase (ALT), lactate dehydrogenase (LDH), an d creatine phosphokinase (CPK) were significantly increased. In the su bchronic study, mice received TQ in drinking water at concentrations o f 0.01, 0.02, and 0.03% for 90 days with no resulting mortality or sig ns of toxicity. The average daily intake of the compound was approxima tely 30, 60, or 90 mg/kg/day. There were no changes of toxicological s ignificance in body and organ weights, food and water intake, or urine and feces output. Tissue GSH, plasma concentrations of TP, urea, crea tinine and triglycerides, and enzyme activities of ALT, LDH, and CPK w ere also not affected. Histological examination revealed no gross or m icroscopic tissue damage. TQ, however, produced a significant decrease in fasting plasma glucose level. The results indicate that the acute oral toxicity of TQ in mice is of a low order and it is generally well tolerated when given subchronically at doses previously shown to have cytoprotective activity Drug Dev. Res. 44:56-61, 1998. (C) 1998 Wiley -Liss, Inc.